Canyon Pharmaceuticals, Inc.
2 clinical trials · Sponsor
◉ Watch Canyon Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis (NCT00913133) | Canyon Pharmaceuticals, Inc. | 2010-03-01 |
| A Comparative Sudy Comparing ArgatrobanĀ® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome (NCT00787332) | Canyon Pharmaceuticals, Inc. | 2008-09-01 |
Track Canyon Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.